Budget Impact Analysis of Obinutuzumab And Ibrutinib In Patients With Chronic Lymphocytic Leukemia In Russia
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1356
https://www.valueinhealthjournal.com/article/S1098-3015(16)32722-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1275
First Page :
A582
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32722-X&doi=10.1016/j.jval.2016.09.1356